Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

PURPOSE: Adoptive immunotherapy using tumor-infiltrating lymphocytes represents an effective cancer treatment for patients with metastatic melanoma. The NY-ESO-1 cancer/testis antigen, which is expressed in 80% of patients with synovial cell sarcoma and approximately 25% of patients with melanoma an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robbins, Paul F., Morgan, Richard A., Feldman, Steven A., Yang, James C., Sherry, Richard M., Dudley, Mark E., Wunderlich, John R., Nahvi, Azam V., Helman, Lee J., Mackall, Crystal L., Kammula, Udai S., Hughes, Marybeth S., Restifo, Nicholas P., Raffeld, Mark, Lee, Chyi-Chia Richard, Levy, Catherine L., Li, Yong F., El-Gamil, Mona, Schwarz, Susan L., Laurencot, Carolyn, Rosenberg, Steven A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2011
Materias:
Original Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068063/
https://ncbi.nlm.nih.gov/pubmed/21282551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.2537
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares